The First Affiliated Hospital of Jinzhou Medical University, Malaysia.
Lincoln University College, Malaysia.
Asian Pac J Cancer Prev. 2024 Sep 1;25(9):3023-3028. doi: 10.31557/APJCP.2024.25.9.3023.
We conducted a study to assess the effectiveness and safety of three different surgical instruments for enucleation in treating high-risk benign prostatic hyperplasia (BPH). These instruments include red laser, green laser, and plasma surgical equipment for enucleation of the prostate.
In a retrospective analysis, 237 patients diagnosed with high-risk benign prostatic hyperplasia (BPH) underwent prostate enucleation using three different groups of surgical instruments at the Department of Urology, the First Affiliated Hospital of Jinzhou Medical University. These groups included the red laser device group (n = 67), the green laser device group (n = 61), and the plasma device group (n = 109). The study evaluated changes in prostate mass, blood loss, operation time, and postoperative efficacy at 1- and 6-month intervals, as well as any associated complications.
The red and green laser surgical instrument groups demonstrated superiority over the plasma group in several aspects. (1) Operation Time: 1 Red laser group: 87.9 ± 14.7 minutes; 1 Green laser group: 86.1 ± 15.3 minutes. (2) Blood Loss: 1 Red laser group: 30.1 ± 5.9 mL; 2Green laser group: 30.9 ± 6.1 mL. (3) Temporary Urinary Incontinence: 1Red laser group: 3 cases (4.48%); 2Green laser group: 2 cases (3.28%). These differences were statistically significant. Additionally, postoperative indicators such as IPSS(International Prostate Prostate Symptom Score), QoL(Quality of Life), Q max(The Maximum Flow Rate), and RUV(Residual Urine Volume) showed significant improvement in all three groups compared to the preoperative state.
Red laser, green laser and plasma surgical devices were safe and effective in the treatment of high critical benign prostatic hyperplasia; laser surgical devices showed better performance in terms of operation time, intraoperative bleeding and complications.
我们开展了一项研究,评估了三种不同的手术器械在治疗高危良性前列腺增生(BPH)中的有效性和安全性。这些器械包括红激光、绿激光和等离子前列腺剜除术设备。
在回顾性分析中,锦州医科大学附属第一医院泌尿外科 237 例高危良性前列腺增生(BPH)患者分别采用三种不同手术器械(红激光组 67 例,绿激光组 61 例,等离子组 109 例)进行前列腺剜除术。研究评估了前列腺质量、出血量、手术时间以及术后 1 个月和 6 个月的疗效变化,以及任何相关并发症。
红激光和绿激光手术器械组在多个方面优于等离子组。(1)手术时间:1红激光组:87.9±14.7 分钟;1绿激光组:86.1±15.3 分钟。(2)出血量:1红激光组:30.1±5.9ml;2绿激光组:30.9±6.1ml。(3)暂时性尿失禁:1红激光组:3 例(4.48%);2绿激光组:2 例(3.28%)。这些差异具有统计学意义。此外,与术前相比,所有三组的术后指标(国际前列腺症状评分(IPSS)、生活质量(QoL)、最大尿流率(Qmax)和残余尿量(RUV))均有显著改善。
红激光、绿激光和等离子前列腺剜除术设备治疗高危良性前列腺增生安全有效;激光手术器械在手术时间、术中出血和并发症方面表现更好。